← Назад к работе
Работы, на которые ссылается эта работа
Работ: 199
Работа: Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?
CAR T therapies in multiple myeloma: unleashing the future
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini +7
Статья2024Цитирований: 2ABIDevelopment of NK cell-based cancer immunotherapies through receptor engineering
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond +1
Статья2024Цитирований: 2ABITumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi +5
Обзорная статья2024Цитирований: 2ABIReshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu +6
Обзорная статья2024Цитирований: 2ABIIn vivo CAR T cell generation to treat cancer and autoimmune disease
Theresa Hunter, Yanjie Bao, Yan Zhang +37
Статья2025Цитирований: 2ABIArtificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives
Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed +4
Обзорная статьяCAR-T cell therapy researchTherapeutic Advances in Vaccines and Immunotherapy2024Цитирований: 1ABI